DRW Securities’s Xtant Medical Holdings XTNT Stock Holding History

DRW Securities’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,500	Closed	-$91K	–	153
2014 Q4	$91K	Hold	2,500	–	–	0.01%	117
2014 Q3	$134K	Buy	+2,500	New	+$166K	0.01%	78

Other funds holding XTNT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

GCM

Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAM

CG Asset Management New York $268M AUM 15.46% 1-Year Est. Return

DRW Securities's XTNT Position: Q1 2015 in Review

DRW Securities sold out of Xtant Medical Holdings (XTNT) in Q1 2015, closing a stake of 2,500 shares — an estimated $91K sold.

DRW Securities first reported a position in XTNT in Q3 2014 and held it in 2 quarters. The position peaked at $134K in Q3 2014. 18 funds tracked by Wall St. Rank hold XTNT as of Q1 2015.

DRW Securities reported no remaining Xtant Medical Holdings position as of Q1 2015 after selling out during the quarter.
DRW Securities sold 2,500 Xtant Medical Holdings shares in Q1 2015, an estimated $91K.
DRW Securities first reported a position in Xtant Medical Holdings in Q3 2014 and held it in 2 quarters.
DRW Securities's Xtant Medical Holdings position peaked at $134K in Q3 2014.
18 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2015.

Based on DRW Securities's 13F filing for Q1 2015, filed 15 May 2015.